Please assess the completion status of the following clinical trial:

Trial Title: High Dose of Amoxicillin and Metronidazole Plus Bismuth For Helicobacter Pylori Treatment

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Participants with non-ulcer functional dyspepsia or peptic ulcer disease~* Ability and willingness to participate in the study and to sign and give informed consent~* Confirmed H. pylori infection and with no previous treatment experience~Exclusion Criteria:~* Less than 18 years old~* With previous gastric surgery~* Major systemic diseases~* Pregnancy or lactation~* Allergy to any of the study drugs Administration of antibiotics, bismuth, antisecretory drugs in 8 weeks prior to inclusion

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 80 Years
- Healthy Volunteers: f

Study Arms:
- Triple Therapy (Type: ACTIVE_COMPARATOR): Esomeprazole 20mg bid, Amoxicillin 1.0g tid and Metronidazole 0.4g tid for 14 days
- Bismuth Plus Triple Therapy (Type: EXPERIMENTAL): Esomeprazole 20mg bid, Bismuth Potassium Citrate 600mg bid, Amoxicillin 1.0g tid and Metronidazole 0.4g tid for 14 days

Based on this trial design, predict the completion outcome and termination type (if applicable).